NewAmsterdam Pharma (NAMS) Payables (2021 - 2026)
NewAmsterdam Pharma's Payables came in at $10.28 million for Q2 2026, up 8.6% from $9.46 million a year earlier and up 27.0% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Payables (2021 - 2026) Analysis & Trends
At the end of FY2025, NewAmsterdam Pharma's Payables was $15.42 million, up 13.3% from FY2024.
- Payables carries a four-year compound annual growth rate of 7.3% (FY2021 to FY2025).
- Going back by year, Payables was $13.61 million in FY2024 (-19.6%), $16.92 million in FY2023 (-13.2%), $19.5 million in FY2022 (+67.7%) and $11.63 million in FY2021.
- The five-year range for quarterly Payables is $8.02 million (Q1 2025) to $22.71 million (Q2 2023).
- Year-over-year, Payables has increased for three consecutive quarters, with an average decline of 4.0% over the last seven quarters.
- The fastest year-over-year change in Payables over five years came in Q4 2022 (growth of 67.9%), and the weakest in Q2 2024 (a decline of 55.1%).
- Business Quant data shows NAMS's Payables at $8.09 million (Q1 2026), $15.42 million (Q4 2025) and $10.1 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | NewAmsterdam Pharma | 2.77 Bn | 2.77 Bn | - | 10.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.28 Mn |
| Mar 31, 2026 | 8.09 Mn |
| Dec 31, 2025 | 15.42 Mn |
| Sep 30, 2025 | 10.10 Mn |
| Jun 30, 2025 | 9.46 Mn |
| Mar 31, 2025 | 8.02 Mn |
| Dec 31, 2024 | 13.61 Mn |
| Sep 30, 2024 | 10.58 Mn |
| Jun 30, 2024 | 10.19 Mn |
| Mar 31, 2024 | 9.97 Mn |
| Dec 31, 2023 | 16.92 Mn |
| Jun 30, 2023 | 22.71 Mn |
| Dec 31, 2022 | 18.88 Mn |
| Dec 31, 2021 | 11.24 Mn |
API Access
NewAmsterdam Pharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();